Drug intelligence / Profile preview

Q-VD-OPh

Development stage
Unknown
Modality
Small Molecules
Administration
Intraperitoneal, Intravenous
01

Overview

Q-VD-OPh is a potent, cell-permeable, and irreversible broad-spectrum caspase inhibitor. It is designed to inhibit a wide range of caspases, including caspase-1, -3, -7, -8, -9, -10, and -12, thereby effectively blocking the apoptotic cell death pathway. Compared to earlier generation inhibitors like Z-VAD-FMK, Q-VD-OPh demonstrates significantly higher potency, superior stability, and markedly reduced cellular toxicity, making it a preferred tool compound for both in vitro and in vivo research. It is frequently utilized in studies to distinguish between different modalities of cell death, such as apoptosis and ferroptosis, and to investigate the role of caspases in neurodegeneration, inflammation, and oncology. Notably, Q-VD-OPh does not inhibit other proteases like calpains or cathepsins at concentrations that fully suppress caspase activity.

Other names
Quinoline-Val-Asp-Difluorophenoxymethyl KetoneQ-VD-OPHQuinoline-Val-Asp(OMe)-OPh
02

Targets

CASP7 (Caspase-7)CASP3 (Caspase-3)CASP12 (Caspase-12)CASP9 (Caspase-9)CASP8 (Caspase-8)CASP10 (Caspase-10)CASP1 (Caspase-1)

Beyond the preview

Go deeper on Q-VD-OPh.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Q-VD-OPh.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call